Netherby, Australia

Timothy Edward Rayner

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Timothy Edward Rayner

Introduction

Timothy Edward Rayner, an inventive mind hailing from Netherby, Australia, has made significant contributions to the field of dermatological treatments. With a focus on enhancing skin health and appearance, his innovative work has garnered attention in the scientific community.

Latest Patents

Rayner holds a patent for a groundbreaking method for treating damage in intact skin. This method involves administering a composition that contains basic milk growth factors in amounts higher than those typically found in milk. The treatment aims to address skin damage caused by various factors, including biological aging, environmental impacts, and medical conditions. In addition to therapeutic applications, his invention also targets the cosmetic improvement of aged skin, effectively treating conditions such as wrinkles, blemishes, and sagging.

Career Highlights

Currently, Timothy Rayner is associated with Novozymes Biopharma Australia Limited, where he continues to advance his research in biopharma solutions. His expertise in dermatology and pharmaceutical compositions places him at the forefront of innovation in skin treatment methodologies.

Collaborations

Rayner collaborates with esteemed professionals in his field, including Allison June Cowin and David Andrew Belford. Together, they contribute to research and development efforts aimed at improving skin health and offering new solutions for patients in need.

Conclusion

Timothy Edward Rayner's commitment to innovative skin treatments exemplifies the role of inventors in advancing healthcare. His unique approach to utilizing basic milk growth factors presents a promising avenue for both therapeutic and cosmetic applications in dermatology. As he continues to work with Novozymes Biopharma Australia Limited and his talented colleagues, the future of skin treatment holds great potential for further breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…